Log in

CVE:NLHNova Leap Health Stock Price, Forecast & News

C$0.35
+0.01 (+2.94 %)
(As of 07/2/2020 08:00 AM ET)
Add
Compare
Today's Range
C$0.35
Now: C$0.35
C$0.35
50-Day Range
C$0.33
MA: C$0.36
C$0.40
52-Week Range
C$0.21
Now: C$0.35
C$0.48
Volume12,000 shs
Average Volume47,290 shs
Market CapitalizationC$22.86 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Nova Leap Health Corp. provides personal home care and support services in the United States and Canada. Its services include companionship; cooking and meal preparation; dementia care; light housekeeping; respite care; transportation; personal care; medication reminders; and medication administration by nursing staff. The company serves clients in the states of Rhode Island, New Hampshire, Vermont, and Massachusetts. Nova Leap Health Corp. is headquartered in Halifax, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars


Industry, Sector and Symbol

Industry Long-Term Care Facilities
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone902-401-9480

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$18.10 million
Cash FlowC$0.04 per share
Book ValueC$0.12 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$22.86 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NLH News and Ratings via Email

Sign-up to receive the latest news and ratings for NLH and its competitors with MarketBeat's FREE daily newsletter.

Nova Leap Health (CVE:NLH) Frequently Asked Questions

How has Nova Leap Health's stock been impacted by COVID-19 (Coronavirus)?

Nova Leap Health's stock was trading at C$0.36 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NLH stock has decreased by 2.8% and is now trading at C$0.35. View which stocks have been most impacted by Coronavirus.

Has Nova Leap Health been receiving favorable news coverage?

Media stories about NLH stock have trended very negative this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Nova Leap Health earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Nova Leap Health.

Who are some of Nova Leap Health's key competitors?

Who are Nova Leap Health's key executives?

Nova Leap Health's management team includes the following people:
  • Mr. Christopher Donald Dobbin C.A., C.P.A., CPA, CA, CEO, Pres & Director (Age 44)
  • Ms. Megan Spidle CPA, C.A., CFO & Corp. Sec. (Age 42)
  • Mr. Michael Gremley, Mang. of Corp. Devel.

What is Nova Leap Health's stock symbol?

Nova Leap Health trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NLH."

How do I buy shares of Nova Leap Health?

Shares of NLH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Nova Leap Health's stock price today?

One share of NLH stock can currently be purchased for approximately C$0.35.

How big of a company is Nova Leap Health?

Nova Leap Health has a market capitalization of C$22.86 million and generates C$18.10 million in revenue each year.

What is Nova Leap Health's official website?

The official website for Nova Leap Health is novaleaphealth.com.

How can I contact Nova Leap Health?

The company can be reached via phone at 902-401-9480.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.